The role of 5′-AMP-activated protein kinase (AMPK) in diabetic nephropathy: A new direction?

  • McMahon K
  • Zanescu D
  • Sood V
 et al. 
  • 8


    Mendeley users who have this article in their library.
  • 1


    Citations of this article.


Diabetic nephropathy (DN) is a microvascular complication of diabetes that is characterized by proteinuria, glomerulosclerosis, and decreased kidney function ultimately leading to end stage renal disease; in fact, DN is the leading cause of end stage renal disease in the western world. Glycemic and blood pressure control are currently the most common forms of prevention and treatment of the disease. However, despite good glycemic and blood pressure control, many patients still progress to end stage renal disease and require renal replacement therapy, leaving investigators searching for novel DN therapy targets. The AMP-activated protein kinase (AMPK) is a heterotrimeric protein that serves as an energy regulator for the cell. However, numerous extracellular factors that contribute to DN progression (including glucose, vascular endothelial growth factor, insulin, and AngII) may inhibit AMPK activity. Two recent studies indicate that AMPK activity decreases during DN progression (Lee et al. Am J Physiol Renal Physiol 292(2):F617-27 and Cammisotto et al. Am J Physiol Renal Physiol. 294(4):F881-F889). In order to better understand the potential role that AMPK inhibition has in DN, we have reviewed the mechanisms of AMPK regulation, how these regulatory mechanisms are changed in DN, and what effect that might have on AMPK activity. Additionally, we discuss the downstream effects of AMPK signaling, and how diminished AMPK activity would affect these events. We hope that this review may stimulate future research into the beneficial effects of up-regulating AMPK in ameliorating DN. © 2009 Bentham Science Publishers Ltd.

Author-supplied keywords

  • adiponectin
  • angiogenesis
  • angiotensin II
  • diabetic nephropathy
  • drug contraindication
  • drug structure
  • drug targeting
  • enzyme activity
  • enzyme regulation
  • enzyme structure
  • enzymology
  • extracellular matrix
  • glitazone derivative
  • human
  • hydroxymethylglutaryl coenzyme A reductase inhibit
  • hydroxymethylglutaryl coenzyme A reductase kinase
  • hyperglycemia
  • insulin resistance
  • leptin
  • metformin
  • nitric oxide
  • nonhuman
  • pathogenesis
  • peroxisome proliferator activated receptor gamma
  • pioglitazone
  • protein expression
  • protein function
  • protein targeting
  • review
  • rosiglitazone
  • structure analysis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • K W McMahon

  • D I Zanescu

  • V Sood

  • E G Beale

  • S S Prabhakar

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free